The Valley Desk

NCT03034772 · Interventional trial

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Overall registry status Completed

Phase 2 · Phase 3

Conditions Neovascular Age-related Macular Degeneration, Wet Macular Degeneration

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov